Franziska Michor - 20 Nov 2024 Form 3 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
Jonathan D. Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
20 Nov 2024
Net transactions value
$0
Form type
3
Filing time
22 Nov 2024, 18:25:19 UTC
Next filing
23 Jun 2025

No securities are beneficially owned.